Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation

  • Calvayrac, Olivier
  • Rodríguez-Calvo, Ricardo
  • Martí-Pamies, Ingrid
  • Alonso, Judith
  • Ferrán, Beatriz
  • Aguiló, Silvia
  • Crespo, Javier
  • Rodríguez-Sinovas, Antonio
  • Tejedor-Rodríguez, Cristina
  • Martínez-González, José
Recent work has highlighted the role of NR4A receptors in atherosclerosis and inflammation. In vascular smooth muscle cell (VSMC) proliferation, however, NOR-1 (neuron-derived orphan receptor-1) exerts antagonistic effects to Nur77 and Nurr1. The aim of this study was to analyse the effect of NOR-1 in VSMC inflammatory response. We assessed the consequence of a gain-of-function of this receptor on the response of VSMC to inflammatory stimuli. In human VSMC, lentiviral over-expression of NOR-1 reduced lipopolysaccharide (LPS)-induced up-regulation of cytokines (IL-1β, IL-6 and IL-8) and chemokines (MCP-1 and CCL20). Similar effects were obtained in cells stimulated with TNFα or oxLDL. Conversely, siRNA-mediated NOR-1 inhibition significantly increased the expression of pro-inflammatory mediators. Interestingly, in the aortas from transgenic mice that over-express human NOR-1 in VSMC (TgNOR-1), the up-regulation of cytokine/chemokine by LPS was lower compared to wild-type littermates. Similar results were obtained in VSMC from transgenic animals. NOR-1 reduced the transcriptional activity of NFκB sensitive promoters (in transient transfections), and the binding of NFκB to its responsive element (in electrophoretic mobility shift assays). Furthermore, NOR-1 prevented the activation of NFκB pathway by decreasing IκBα phosphorylation/degradation and inhibiting the phosphorylation and subsequent translocation of p65 to the nucleus (assessed by Western blot and immunocytochemistry). These effects were associated with an attenuated phosphorylation of ERK1/2, p38 MAPK and Jun N-terminal kinase, pathways involved in the activation of NFκB. In mouse challenged with LPS, the activation of the NFκB signalling was also attenuated in the aorta from TgNOR-1. Our data support a role for NOR-1 as a negative modulator of the acute response elicited by pro-inflammatory stimuli in the vasculature., This work was supported by the Sociedad Española de Cardiología (Proyecto Fundación Española del Corazón para Investigación Básica en Cardiología 2011) and Spanish Ministerio de Economía y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2009-11949, SAF2012-40127, PI12/01952, RD12/0042/0053 and RD12/0042/0021]. Judith Alonso is supported by a Ph.D. fellowship (FPU) from the Spanish Ministerio de Educación, and Beatriz Ferrán by a JAE-Pre from the Consejo Superior de Investigaciones Científicas (CSIC)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single Intracoronary Injection of Encapsulated Antagomir-92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling

  • Bellera Gotarda, Neus|||0000-0002-1040-0900
  • Barba, Ignasi|||0000-0001-9886-3776
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Ferret, Eulalia
  • Asín, Miguel Angel
  • Gonzalez-Alujas, MªTeresa
  • Pérez-Rodón, Jordi|||0000-0003-2234-5248
  • Esteves, Marielle
  • Fonseca, Carla
  • Toran, Nuria
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Pérez, Amadeo
  • García-Dorado, David|||0000-0002-1126-1279
Small and large preclinical animal models have shown that antagomir-92a-based therapy reduces early postischemic loss of function, but its effect on postinfarction remodeling is not known. In addition, the reported remote miR-92a inhibition in noncardiac organs prevents the translation of nonvectorized miR-targeted therapy to the clinical setting. We investigated whether a single intracoronary administration of antagomir-92a encapsulated in microspheres could prevent deleterious remodeling of myocardium 1 month after acute myocardial infarction AUTHOR: Should "acute" be added before "myocardial infarction" (since abbreviation is AMI)? Also check at first mention in main text (AMI) without adverse effects. In a percutaneous pig model of reperfused AMI, a single intracoronary administration of antagomir-92a encapsulated in specific microspheres (9 μm poly-d,-lactide-co-glycolide [PLGA]) inhibited miR-92a in a local, selective, and sustained manner (n=3 pigs euthanized 1, 3, and 10 days after treatment; 8×, 2×, and 5×-fold inhibition at 1, 3, and 10 days). Downregulation of miR-92a resulted in significant vessel growth (n=27 adult minipigs randomly allocated to blind receive encapsulated antagomir-92a, encapsulated placebo, or saline [n=8, 9, 9]; P =0.001), reduced regional wall-motion dysfunction (P =0.03), and prevented adverse remodeling in the infarct area 1 month after injury (P =0.03). Intracoronary injection of microspheres had no significant adverse effect in downstream myocardium in healthy pigs (n=2), and fluorescein isothiocyanate albumin-PLGA microspheres were not found in myocardium outside the left anterior descending coronary artery territory (n=4) or in other organs (n=2). Early single intracoronary administration of encapsulated antagomir-92a in an adult pig model of reperfused AMI prevents left ventricular remodeling with no local or distant adverse effects, emerging as a promising therapeutic approach to translate to patients who suffer a large AMI.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium

  • Fernández Sanz, Celia
  • Ruiz-Meana, M.
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Nuñez, E.
  • Castellano, J.
  • Loureiro, M.
  • Barba, Ignasi|||0000-0001-9886-3776
  • Poncelas, M.
  • Rodriguez-Sinovas, A.
  • Vázquez, Jesús|||0000-0003-1461-5092
  • García-Dorado, David|||0000-0002-1126-1279
Mitochondrial alterations are critically involved in increased vulnerability to disease during aging. We investigated the contribution of mitochondria-sarcoplasmic reticulum (SR) communication in cardiomyocyte functional alterations during aging. Heart function (echocardiography) and ATP/phosphocreatine (NMR spectroscopy) were preserved in hearts from old mice (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia, between bench and bedside

  • Cabrera-Fuentes, H. A.|||0000-0002-8502-7098
  • Alba-Alba, Corina
  • Aragones, Julian
  • Bernhagen, Jürgen
  • Boisvert, William A.
  • Bøtker, Hans Erik|||0000-0001-6358-8962
  • Cesarman-Maus, Gabriela
  • Fleming, Ingrid
  • García-Dorado, David|||0000-0002-1126-1279
  • Lecour, Sandrine|||0000-0003-1942-8974
  • Liehn, Elisa
  • Marber, Michael S.
  • Marina, Nephtali
  • Mayr, Manuel
  • Perez-Mendez, Oscar
  • Miura, Tetsuji|||0000-0001-5024-7085
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Salinas-Estefanon, Eduardo M.
  • Ong, Sang-Bing
  • Schnittler, Hans J.
  • Sanchez-Vega, Jose T.
  • Sumoza-Toledo, Adriana
  • Vogel, Carl-Wilhelm
  • Yarullina, Dina
  • Yellon, Derek|||0000-0001-7791-9320
  • Preissner, Klaus T.
  • Hausenloy, Derek J.
Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. Although a number of pathological situations such as ischemia-reperfusion injury or atherosclerosis can be simulated and manipulated in diverse animal models, also to challenge new drugs for intervention, patient studies are the ultimate litmus test to obtain unequivocal information about the validity of biomedical concepts and their application in the clinics. Thus, the open and bidirectional exchange between bench and bedside is crucial to advance the field of ischemic heart disease with a particular emphasis of understanding long-lasting approaches in cardioprotection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hospital and 4-year mortality predictors in patients with acute pulmonary edema with and without coronary artery disease

  • Figueras Bellot, Jaime
  • Bañeras, Jordi|||0000-0002-7395-0862
  • Peña-Gil, Carlos
  • Barrabés, José A.|||0000-0001-7062-6277
  • Rodríguez Palomares, José Fernando|||0000-0002-8822-5532
  • García-Dorado, David|||0000-0002-1126-1279
Long-term prognosis of acute pulmonary edema () remains ill defined. We evaluated demographic, echocardiographic, and angiographic data of 806 consecutive patients with with () and without coronary artery disease (non-) admitted from 2000 to 2010. Differences between hospital and long-term mortality and its predictors were also assessed. patients (n=638) were older and had higher incidence of diabetes and peripheral vascular disease than non- (n=168), and lower ejection fraction. Hospital mortality was similar in both groups (26.5% vs 31.5%; P =0.169) but recurrence was higher in patients (17.3% vs 6.5%; P <0.001). Age, admission systolic blood pressure, recurrence of , and need for inotropics or endotracheal intubation were the main independent predictors of hospital mortality. In contrast, overall mortality (70.0% vs 57.1%; P =0.002) and readmission for nonfatal heart failure after a 45-month follow-up (10-140; 17.3% vs 7.6%; P =0.009) were higher in than in non- patients. Age, peripheral vascular disease, and peak creatine kinase during index hospitalization, but not ejection fraction, were the main independent predictors of overall mortality, whereas coronary revascularization or valvular surgery were protective. These interventions were mostly performed during hospitalization index (294 of 307; 96%) and not intervened patients showed a higher risk profile. Long-term mortality in is high and higher in than in non- patients. Considering the different in-hospital and long-term mortality predictors herein described, which do not necessarily involve systolic function, it is conceivable that a more aggressive interventional program might improve survival in high-risk patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

New protein-protein interactions of mitochondrial connexin 43 in mouse heart

  • Denuc, Amanda
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Calvo, Enrique
  • Loureiro, Marta
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Guarás, Adela
  • Vázquez, Jesús|||0000-0003-1461-5092
  • García-Dorado, David|||0000-0002-1126-1279
Connexin 43 (Cx43), the gap junction protein involved in cell-to-cell coupling in the heart, is also present in the subsarcolemmal fraction of cardiomyocyte mitochondria. It has been described to regulate mitochondrial potassium influx and respiration and to be important for ischaemic preconditioning protection, although the molecular effectors involved are not fully characterized. In this study, we looked for potential partners of mitochondrial Cx43 in an attempt to identify new molecular pathways for cardioprotection. Mass spectrometry analysis of native immunoprecipitated mitochondrial extracts showed that Cx43 interacts with several proteins related with mitochondrial function and metabolism. Among them, we selected for further analysis only those present in the subsarcolemmal mitochondrial fraction and known to be related with the respiratory chain. Apoptosis-inducing factor () and the beta-subunit of the electron-transfer protein (), two proteins unrelated to date with Cx43, fulfilled these conditions, and their interaction with Cx43 was proven by direct and reverse co-immunoprecipitation. Furthermore, a previously unknown molecular interaction between and was established, and protein content and sub-cellular localization appeared to be independent from the presence of Cx43. Our results identify new protein-protein interactions between -Cx43, -Cx43 and - as possible players in the regulation of the mitochondrial redox state.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction, trials and tribulations

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cardiomyocyte hypertrophy induced by Endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin

  • Blasco, Natividad
  • Cámara, Yolanda|||0000-0003-2458-6942
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Beà, Aida|||0000-0002-9733-4618
  • Barés, Gisel
  • Forne, Carles|||0000-0002-8133-3274
  • Ruíz-Meana, Marisol
  • Girón, Cristina
  • Barba, Ignasi|||0000-0001-9886-3776
  • García Arumí, Elena|||0000-0003-1848-005X
  • García-Dorado, David|||0000-0002-1126-1279
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Llovera, Marta
  • Sanchis, Daniel
The endonuclease G gene (Endog), which codes for a mitochondrial nuclease, was identified as a determinant of cardiac hypertrophy. How ENDOG controls cardiomyocyte growth is still unknown. Thus, we aimed at finding the link between ENDOG activity and cardiomyocyte growth. Endog deficiency induced reactive oxygen species (ROS) accumulation and abnormal growth in neonatal rodent cardiomyocytes, altering the AKT-GSK3β and Class-II histone deacethylases (HDAC) signal transduction pathways. These effects were blocked by ROS scavengers. Lack of ENDOG reduced mitochondrial DNA (mtDNA) replication independently of ROS accumulation. Because mtDNA encodes several subunits of the mitochondrial electron transport chain, whose activity is an important source of cellular ROS, we investigated whether Endog deficiency compromised the expression and activity of the respiratory chain complexes but found no changes in these parameters nor in ATP content. MtDNA also codes for humanin, a micropeptide with possible metabolic functions. Nanomolar concentrations of synthetic humanin restored normal ROS levels and cell size in Endog -deficient cardiomyocytes. These results support the involvement of redox signaling in the control of cardiomyocyte growth by ENDOG and suggest a pathway relating mtDNA content to the regulation of cell growth probably involving humanin, which prevents reactive oxygen radicals accumulation and hypertrophy induced by Endog deficiency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte, Javier|||0000-0003-2283-3591
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
  • Mayor, F.
Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in the 1 H NMR metabolic profile of serum in cardiovascular risk patients

  • Barba, Ignasi|||0000-0001-9886-3776
  • Andrés Villareal, Mireia|||0000-0002-0657-5855
  • Picón, Irene
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • García-Dorado, David|||0000-0002-1126-1279
Personalized diagnosis and risk stratification of cardiovascular diseases would allow optimizing therapeutic strategies and lifestyle changes. Metabolomics is a promising technique for personalized diagnosis and prognosis; however, various physiological parameters, including sex, influence the metabolic profile thus hampering its translation to the clinic. Knowledge of the variation in the metabolic profile associated with sex would facilitate metabolomic translation to the clinic. The objective of the present work was to investigate the possible differences in the metabolic H NMR profile associated to sex beyond lipoproteins. H NMR spectra from whole serum and methanol deproteinized samples from 39 patients (22 males, 17 females) between 55-70 years old with suspected coronary artery disease that underwent a stress test that was considered negative where included. Deproteinized serum could be used to differentiate sex based on higher levels of lactate and glucose in women. Lipoprotein region was the most variable area of the spectra between individuals, but spectra of whole serum were able to differentiate sex based on lipoproteins. There are sex-related differences in the H NMR metabolic profile of individuals with suspected cardiovascular disease beyond lipoproteins. These findings may help the translation of metabolomics to the clinic.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size

  • Valls-Lacalle, Laura|||0000-0002-7185-0454
  • Barba, Ignasi|||0000-0001-9886-3776
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
Inhibition of succinate dehydrogenase (SDH) with malonate during reperfusion reduces infarct size in isolated mice hearts submitted to global ischemia. However, malonate has toxic effects that preclude its systemic administration in animals. Here we investigated the effect of intracoronary malonate on infarct size in pigs submitted to transient coronary occlusion. Under baseline conditions, 50 mmol/L of intracoronary disodium malonate, but not lower concentrations, transiently reduced systolic segment shortening in the region perfused by the left anterior descending coronary artery (LAD) in open-chest pigs. To assess the effects of SDH inhibition on reperfusion injury, saline or malonate 10 mmol/L were selectively infused into the area at risk in 38 animals submitted to ischemia-reperfusion. Malonate improved systolic shortening in the area at risk two hours after 15 min of ischemia (0.18 ± 0.07 vs 0.00 ± 0.01 a.u., p = 0.025, n = 3). In animals submitted to 40 min of ischemia, malonate reduced reactive oxygen species production (MitoSOX staining) during initial reperfusion and limited infarct size (36.46 ± 5.35 vs 59.62 ± 4.00%, p = 0.002, n = 11), without modifying reperfusion arrhythmias. In conclusion, inhibition of SDH with intracoronary malonate during early reperfusion limits reperfusion injury and infarct size in pigs submitted to transient coronary occlusion without modifying reperfusion arrhythmias or contractile function in distant myocardium.
Dipòsit Digital de Documents de la UAB
Publicación Contribución de congreso (ConferenceOutput)

Ischaemic conditioning and targeting reperfusion injury, a 30 year voyage of discovery

  • Hausenloy, Derek J.
  • Barrabés, José A.|||0000-0001-7062-6277
  • Bøtker, Hans Erik|||0000-0001-6358-8962
  • Davidson, Sean M.|||0000-0001-5182-4980
  • Di Lisa, Fabio
  • Downey, James
  • Engstrom, Thomas
  • Ferdinandy, Péter|||0000-0002-6424-6806
  • Carbrera-Fuentes, Hector A.
  • Heusch, Gerd
  • Ibañez, Borja|||0000-0002-5036-254X
  • Iliodromitis, Efstathios K.
  • Inserte, Javier|||0000-0003-2283-3591
  • Jennings, Robert
  • Kalia, Neena
  • Kharbanda, Rajesh
  • Lecour, Sandrine|||0000-0003-1942-8974
  • Marber, Michael
  • Miura, Tetsuji|||0000-0001-5024-7085
  • Ovize, Michel
  • Perez-Pinzon, Miguel A.
  • Piper, Hans Michael
  • Przyklenk, Karin
  • Schmidt, Michael Rahbek
  • Redington, Andrew
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Vinten-Johansen, Jakob
  • Yellon, Derek|||0000-0001-7791-9320
  • García-Dorado, David|||0000-0002-1126-1279
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.